Advocacy, Policy, & Funding Resources

Factsheets Reports Policy Briefs Strategies & Frameworks Videos & Webinars Other

Factsheets

The Urgent Need for New TB Vaccines
TB Vax ARM (2024)
Information and talking points about the importance of TB vaccines to meeting global targets to end TB and the need to invest in TB vaccine R&D.

Member States must commit to invest in TB vaccine R&D
TB Vax ARM (2023)
One pager on why Member States must commit to substantially increasing adequate, predictable, and sustainable financing for TB vaccine R&D at the UN High-Level Meeting on TB.

Modeling in TB vaccine development
WGNV (2022)
An overview of mathematical modeling for TB vaccines, such as public health impact and cost-effective modeling, and how modeling can be used to support TB vaccine advocacy efforts.

Reports

2024 Report on TB Research Funding Trends (2005-2023)
Treatment Action Group (2024)
Annual report tracking public, private, philanthropic, and multilateral investments in TB R&D across: basic science, diagnostics, drugs, vaccines, operational research, and infrastructure/unspecified.

Investing in innovation and equitable access to end the tuberculosis epidemic
Results UK & Results Canada (2024)
This report presents the case with a series of recommendations for meeting the financial targets for TB R&D to ensure all people can benefit from scientific progress.

TB Vaccine Advocacy & Acceptance in South Africa: A Scoping Study
Eh!Woza (2024)
A preliminary scoping report gathering a range of perspectives to provide early-stage insights into TB vaccine advocacy and acceptance in South Africa, including a stakeholder map and semi-structured interviews with representatives from each sector.

An investment case for new tuberculosis vaccines
WHO (2022)
Summarizes the full value proposition for new TB vaccines to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation.

A Q&A on how this work can be best used for TB vaccine advocacy is available here

Accountability to End Tuberculosis: A Global Responsibility
RESULTS UK (2023)
Ahead of the 2023 UNHLM on TB, this report makes the case for accountability within the global TB response, highlighting the lack of progress against the 2018 global commitments.

Ready Next Time
Campaigns in Global Health (2023)
Maps the intersection between efforts to strengthen pandemic prevention, preparedness and response (PPPR) systems and efforts to end TB, setting out how policymakers and funders can deliver impact across both agendas.

A Deadly Divide:
TB Commitments vs TB Realities
Stop TB Partnership (2023)
Developed by the Stop TB Partnership Communities, Developing Country NGO, and Developed Country NGO Delegations with input from over 1,000 civil society and affected community partners from 92 countries, this report analyzes progress against a series of commitments made by world leaders at the UNHLM on TB in 2018 and lays out six calls to action to end TB.

Policy Briefs

Elevating the Leadership of High TB Burden G20 States in the Development and Delivery of New TB Vaccines
TB Vax ARM (2024)
This brief explores opportunities to elevate the leadership of high TB burden G20 states through enhanced multilateral cooperation and leveraging global networks, instruments, and partnerships.

Investment Toolbox to Advance TB Vaccine Development through Joint Action
TB Vax ARM (2023)
This brief outlines recommendations for G20 members to act together to accelerate TB vaccine development. The proposed "investment toolbox' is adaptable to each country's economic and research capacities and disease burden.

New TB vaccines needed to tackle AMR
TB Vax ARM (2024)
The brief, from the TB Vax ARM, draws on the latest research in health and economic modelling to demonstrate how new TB vaccines could significantly help control drug-resistant TB and contribute to the antimicrobial resistance (AMR) agenda, in a cost-effective and affordable way.

New Fair Share Targets for TB Research: 0.1% -> 0.15%
Treatment Action Group (2023)
This Information Note provides details, including on the methodology and data sources, on the target for each country to spend at least 0.15% of its overall R&D expenditures on TB R&D to meet global TB research funding goals.

Strategies & Frameworks

Evidence Considerations for Vaccine Policy (ECVP) framework
WHO (2022)
A novel kind of guidance for vaccine development stakeholders that aims to provide early information on the data and evidence that is likely to be required to support WHO policy recommendations.

Global Framework to prepare for Country Introduction of New TB Vaccines for Adults & Adolescents
WHO (2023)
This framework intends to facilitate the planning, investments, and preparation for the rapid introduction and scale-up of TB vaccines for adults and adolescents with sufficient, sustainable and timely supply.

Global Plan to End TB 2023-2030
Stop TB Partnership (2022)
A costed plan and roadmap for a concerted response to TB aligned with the WHO End TB Strategy, including a strategic framework for TB vaccine R&D.

End TB Strategy
WHO (2014)
Provides a 20-year strategy toward the goal of ending the TB pandemic, including the research, development, and implementation of new tools.

Videos & Webinars

TB Vaccine Development: The Next Chapter Starts Now
Treatment Action Group (2024)
Intended for community members, civil society, advocates, and other interested stakeholders, this webinar provides an overview of the TB vaccine pipeline, scientific challenges in TB vaccine development, and advocacy opportunities.

Phumeza Tisile reflects on new TB vaccines
WGNV (2022)
Phumeza Tisile talk about her challenges in facing extensively drug-resistant TB, her vision of a TB free world, and how we can achieve it with new TB vaccines.

#TBVoices videos
TB Vax ARM (2022)
Watch the #TBVoices videos to hear from members of the global TB community about why we need new TB vaccines

Other

TB Vaccine Preparedness Repository
SMART4TB & KNCVTB PLUS (2024)
This is a communications tool for partners, stakeholders, and anyone affected or working in TB. The guide is a key instrument to encourage positive change, sensitize, promote appropriate language, end the stigmatization, and empower people affected by TB.

Words Matter
Stop TB Partnership (2022)
This is a communications tool for partners, stakeholders, and anyone affected or working in TB. The guide is a key instrument to encourage positive change, sensitize, promote appropriate language, end the stigmatization, and empower people affected by TB.

Contact us if you have resources related to advocacy, policy, and funding for TB vaccine R&D that you would like to share.

Advocacy, Policy, & Funding Resources

Factsheets

Reports

Policy Briefs

Strategies & Frameworks

Videos & Webinars

Other

Get Involved

Useful Links

About WGNV

Our Priorities

TB Vaccine Pipeline

Resources

Become a Member

Take Action